WR Biotech, LLC
Tampa, FL
- UEI
- HLVEXZFJKCF2
- CAGE
- 8MVD8
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3802 Spectrum Blvd #142a, Tampa, FL 33612, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Protection of transplanted heart function by regulation of NA/k pump activity - the objective of this proposal is to… | National Heart Lung and Blood Institute | $275,739 | |
| Protection of donor kidneys with synchronization modulation electric field (smef) - the goals of this phase II… | National Institute of Diabetes and Digestive and Kidney Diseases | $2,484,387 | |
| Protection of donor kidneys with synchronization modulation electric field (smef) - the objective of this proposal is to… | National Institute of Diabetes and Digestive and Kidney Diseases | $680,183 |
About WR Biotech, LLC
WR Biotech, LLC is a partnership or limited liability company based entity registered in SAM.gov as a self-certified small disadvantaged business and for-profit organization. It appears to specialize in developing novel biomedical technologies and techniques.
Through federal grant awards from the National Institutes of Health (NIH), WR Biotech has conducted research on an innovative technique called Improved Synchronization Modulation Electric Field (I-SMEF). This involves applying an electric field to regulate the activity of sodium-potassium pumps in cells, with the goals of maintaining pump function, generating ATP, and ultimately protecting organs from ischemic injury during transplantation. Under a $275,739 grant from NIH's National Heart, Lung, and Blood Institute, WR Biotech examined using I-SMEF to protect donor hearts and improve transplanted heart graft function in mice during cold storage prior to transplantation. The company has also received over $3 million in grants from NIH's National Institute of Diabetes and Digestive and Kidney Diseases to study the translational potential of I-SMEF for protecting donor kidneys. This included assessing the technique in preclinical studies using a porcine kidney autotransplantation model, as well as optimizing parameters like electrode configuration and voltage in preparation for potential human trials.
Quick answers
What is WR Biotech, LLC's UEI?
WR Biotech, LLC's Unique Entity ID (UEI) in SAM.gov is HLVEXZFJKCF2.
What is WR Biotech, LLC's CAGE code?
WR Biotech, LLC's CAGE code is 8MVD8.
What is WR Biotech, LLC's primary NAICS code?
WR Biotech, LLC's primary NAICS code is 339112 (Surgical and Medical Instrument Manufacturing).
Where is WR Biotech, LLC located?
WR Biotech, LLC's physical address in SAM.gov is 3802 Spectrum Blvd #142a, Tampa, FL 33612, USA.
Is WR Biotech, LLC registered in SAM.gov?
Yes. WR Biotech, LLC's SAM.gov registration is active through July 1, 2027.
What is WR Biotech, LLC's most recent federal award?
WR Biotech, LLC's most recent federal grant award is Protection of transplanted heart function by regulation of NA/k pump activity - the objective of this proposal is to… (R41HL165958), from National Heart Lung and Blood Institute, on September 7, 2023.
On GovTribe
See WR Biotech, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors